Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

54
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
54
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

275
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
275
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

103
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
103
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The economic evaluation of chronic obstructive pulmonary disease care: Quality and cost - a web of science-based systematic review.

Respiratory medicine·2026
Same author

The Academic Hunger Gap: From Plates to Well-Being-How Food Insecurity Undermines Quality of Life in University Students.

Food science & nutrition·2026
Same author

Human metapneumovirus: an emerging public health threat and harbinger of a new pandemic.

GMS hygiene and infection control·2025
Same author

Identifying future risk factors of uncontrolled asthma control: the TAAR study perspective.

The Journal of asthma : official journal of the Association for the Care of Asthma·2025
Same author

Predictors of Intercultural Sensitivity in Medical Students: An Assessment in a Turkish University in an Era of Global Healthcare.

Journal of immigrant and minority health·2025
Same author

Being a woman researcher in dangerous laboratories: biosafety level 3 and tuberculosis.

Philosophy, ethics, and humanities in medicine : PEHM·2025

Related Experiment Video

Updated: Aug 15, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Does Cardiovascular Disease Risk Decrease after Smoking Cessation in Occupational Risk Groups?

Nurgül Bozkurt1, Süleyman Utku Uzun2, Ali Ihsan Bozkurt3

  • 1Akdeniz University, Medical Faculty, Department of Chest Diseases, Antalya, Turkey.

Heart Views : the Official Journal of the Gulf Heart Association
|January 6, 2023
PubMed
Summary
This summary is machine-generated.

Quitting smoking significantly reduces cardiovascular disease (CVD) risk in employees within six months. This study demonstrates substantial improvements in Framingham Risk Score and 10-year CVD risk for workers who successfully cease smoking.

Keywords:
Cardiovascular diseaseFramingham Risk Scoresmokingsmoking cessation

More Related Videos

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

6.1K
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

34.2K

Related Experiment Videos

Last Updated: Aug 15, 2025

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K
Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells
09:15

Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells

Published on: May 11, 2020

6.1K
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

34.2K

Area of Science:

  • Occupational Health
  • Cardiovascular Disease Prevention
  • Public Health

Background:

  • Workplace smoking poses significant health risks, including increased cardiovascular disease (CVD) potential.
  • Assessing CVD risk factors like Framingham Risk Score (FRS) is crucial for employee well-being.
  • Environmental exposures in the workplace can exacerbate health risks for smokers.

Purpose of the Study:

  • To evaluate changes in Framingham Risk Score (FRS) and 10-year CVD risk among employees after smoking cessation.
  • To determine the short-term impact of smoking cessation on cardiovascular health indicators in a working population.

Main Methods:

  • A prospective study involving 562 employees aiming to quit smoking.
  • Calculation of baseline and 6-month FRS and 10-year CVD risk.
  • Assessment of anxiety and depression symptoms using the Hospital Anxiety and Depression Scale.

Main Results:

  • After 6 months, 37% of participants successfully quit smoking.
  • A statistically significant reduction in FRS was observed in those who quit (P < 0.001).
  • Quitters showed a 47.6% decrease in 10-year coronary heart disease risk compared to 14.9% in non-quitters (P < 0.001).
  • Significant decreases in fasting blood glucose levels were noted post-cessation (P = 0.003).

Conclusions:

  • Smoking cessation effectively reduces FRS and CVD risk in employees within six months.
  • Nearly half of employees who quit smoking experienced a reduction in CVD risk in a short timeframe.
  • Implementing smoking cessation programs in the workplace can yield rapid improvements in cardiovascular health.